Riskpilot← Back to searchSign inGet full accessABBOTT NORGE AS
ASActiveOrg 957212158Rolfsbuktveien 4C, 1364 FornebuWholesale of pharmaceutical and medical goods · NACE 4646Est. 199051 employees
Revenue 2024
NOK 571,1M
+12% vs 2023
EBITDA margin
4.4%
-26% vs 2023
Equity ratio
46.7%
Financial strength
Net profit 2024
NOK 20,9M
-19% vs 2023
| Revenue | NOK 571,1M | +12% |
| EBITDA | NOK 25,3M | -26% |
| Net profit | NOK 20,9M | -19% |
| Total assets | NOK 284,1M | +35% |
| Equity | NOK 132,7M | +19% |
| Employees | 51 | — |
Legal name
ABBOTT NORGE AS
Org number
957212158
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. mars 1990
Share capital
NOK 500 000
Employees
51 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Å drive handel, produksjon, forskning, utvikling og markedsføring av produkter og produksjonsteknikker innen bioteknologi, deltakelse i andre selskaper, samt å yte administrative, operasjonelle, finansielle, forretningsmessige, forskningsmessige eller industrielle tjenester til enhver tredjepart, aksjeeier, datterselskap, tilknyttet selskap, herunder også lån, forskudd og garantier, samt annen virksomhet som hermed er forbundet.
Address
Rolfsbuktveien 4C, 1364 Fornebu
Phone
+4781559920
Email
kundehjelp@abbot.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 391 406 | 483 964 | 460 489 | 508 559 | 571 134 |
| Staff expenses | −73 119 | −0 | −0 | −91 752 | −86 835 |
| EBITDA | 48 274 | 21 474 | 24 544 | 34 152 | 25 318 |
| Depreciation & amort. | −38 983 | −3 376 | −3 693 | −3 543 | −3 341 |
| EBIT | 9 291 | 18 098 | 20 852 | 30 609 | 21 977 |
| Net financials | −206 | −970 | 231 | 2 768 | 5 231 |
| Profit before tax | 9 085 | 17 128 | 21 082 | 33 377 | 27 209 |
| Tax | 2 105 | 3 911 | −0 | 7 599 | 6 266 |
| Net profit | 6 980 | 13 217 | 16 139 | 25 778 | 20 943 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 149 080 | 160 287 | 181 715 | 210 169 | 284 073 |
| Equity | 56 653 | 69 870 | 86 009 | 111 787 | 132 729 |
| Long-term debt | 363 | 424 | 596 | 587 | 514 |
| Short-term debt | 92 064 | 89 993 | 95 110 | 97 795 | 150 685 |
| Total debt | 92 427 | 90 417 | 95 706 | 98 382 | 151 198 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20202024
Equity ratio
46.7%
This company
38.2%
Market median
+22% vs market
20202024
Return on equity
15.8%
This company
18.4%
Market median
+14% vs market
20202024
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
20202024
Asset turnover
2.01×
This company
1.12×
Market median
+79% vs market
20202024
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2024 | |
| Former (2) | ||
| Chairman | 2022 – 2023 | |
| Board of Directors | 2019 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Abbott Sa | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ABBOTT NORGE AS 
ABBOTT MEDICAL NORWAY ASBoard members of ABBOTT NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Andreas Almroth | Chief Executive Officer | 0 companies |
| Bradley Jay Slater | Board of Directors | 0 companies |
| Ole Martin Alfstad Christiansen | Chairman | 0 companies |
| Björn Fredrik Anders Björnulfson | Chairman | 0 companies |
| Benjamin Edward Oosterbaan | Board of Directors | 0 companies |